Clinical Trial Update: Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing gemcitabine/vinorelbine, gemcitabine/cisplatin, and gemcitabine/capecitabine in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED